Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1983 Feb 1;128(3):289–292.

Multiple malignant neoplasms 40 years after angiography with Thorotrast.

P Silpananta, F F Illescas, H Sheldon
PMCID: PMC1874778  PMID: 6295588

Full text

PDF
289

Images in this article

289FIG. 1
on p.289
290FIG. 2
on p.290
290FIG. 3
on p.290
290FIG. 4
on p.290
291FIG. 5
on p.291
291FIG. 6
on p.291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbatt J. D. History of the use and toxicity of thorotrast. Environ Res. 1979 Feb;18(1):6–12. [PubMed] [Google Scholar]
  2. BASERGA R., YOKOO H., HENEGAR G. C. Thorotrast-induced cancer in man. Cancer. 1960 Sep-Oct;13:1021–1031. doi: 10.1002/1097-0142(196009/10)13:5<1021::aid-cncr2820130524>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  3. Dahlgren S. Late effects of thorium dioxide on the liver of patients in Sweden. Ann N Y Acad Sci. 1967 Dec 11;145(3):718–723. doi: 10.1111/j.1749-6632.1967.tb50272.x. [DOI] [PubMed] [Google Scholar]
  4. Faber M. Twenty-eight years of continuous follow-up of patients injected with thorotrast for cerebral angiography. Environ Res. 1979 Feb;18(1):37–43. doi: 10.1016/0013-9351(79)90135-x. [DOI] [PubMed] [Google Scholar]
  5. Harrist T. J., Schiller A. L., Trelstad R. L., Mankin H. J., Mays C. W. Thorotrast-associated sarcoma of bone: A case report and review of the literature. Cancer. 1979 Dec;44(6):2049–2058. doi: 10.1002/1097-0142(197912)44:6<2049::aid-cncr2820440615>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  6. Kaul A., Noffz W. Tissue dose in thorotrast patients. Health Phys. 1978 Jul;35(1):113–121. doi: 10.1097/00004032-197807000-00010. [DOI] [PubMed] [Google Scholar]
  7. Kojiro M., Kawano Y., Kawasaki H., Nakashima T., Ikezaki H. Thorotrast-induced hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma in a single patient. Cancer. 1982 May 15;49(10):2161–2164. doi: 10.1002/1097-0142(19820515)49:10<2161::aid-cncr2820491029>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  8. Macmahon H. E., Murphy A. S., Bates M. I. Endothelial-Cell Sarcoma of Liver Following Thorotrast Injections. Am J Pathol. 1947 Jul;23(4):585–611. [PMC free article] [PubMed] [Google Scholar]
  9. Mori T., Kato Y., Shimamine T., Watanabe S. Statistical analysis of Japanese thorotrast-administered autopsy cases. Environ Res. 1979 Feb;18(1):231–244. doi: 10.1016/0013-9351(79)90157-9. [DOI] [PubMed] [Google Scholar]
  10. Popper H., Thomas L. B., Telles N. C., Falk H., Selikoff I. J. Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol. 1978 Aug;92(2):349–376. [PMC free article] [PubMed] [Google Scholar]
  11. Rubel L. R., Ishak K. G. Thorotrast-associated cholangiocarcinoma: an epidemiologic and clinicopathologic study. Cancer. 1982 Oct 1;50(7):1408–1415. doi: 10.1002/1097-0142(19821001)50:7<1408::aid-cncr2820500728>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  12. Ruoslahti E., Salaspuro M., Pihko H., Andersson L., Seppälä M. Serum alpha-fetoprotein: diagnostic significance in liver disease. Br Med J. 1974 Jun 8;2(5918):527–529. doi: 10.1136/bmj.2.5918.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Smoron G. L., Battifora H. A. Thorotrast-induced hepatoma. Cancer. 1972 Nov;30(5):1252–1259. doi: 10.1002/1097-0142(197211)30:5<1252::aid-cncr2820300517>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  14. Suckow E. E., Henegar G. C., Baserga R. Tumors of the Liver Following Administration of Thorotrast. Am J Pathol. 1961 Jun;38(6):663–677. [PMC free article] [PubMed] [Google Scholar]
  15. Telles N. C., Thomas L. B., Popper H., Ishak K. G., Falk H. Evolution of thorotrast-induced hepatic angiosarcomas. Environ Res. 1979 Feb;18(1):74–87. [PubMed] [Google Scholar]
  16. Vogel C. L., Primack A., McIntire K. R., Carbone P. P., Anthony P. P. Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations. Cancer. 1974 Apr;33(4):959–964. doi: 10.1002/1097-0142(197404)33:4<959::aid-cncr2820330410>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  17. Wegener K., Leipolz-Angermüller S. Double tumours of the liver following intravenous thorotrast injection. Patho-anatomical report on two cases. Virchows Arch A Pathol Anat Histol. 1979 May 14;382(1):63–71. doi: 10.1007/BF01102741. [DOI] [PubMed] [Google Scholar]
  18. Winberg C. D., Ranchod M. Thorotrast induced hepatic cholangiocarcinoma and angiosarcoma. Hum Pathol. 1979 Jan;10(1):108–112. doi: 10.1016/s0046-8177(79)80079-9. [DOI] [PubMed] [Google Scholar]
  19. da Motta L. C., Horta J. da S., Tavares M. H. Prospective epidemiological study of thorotrast-exposed patients in Portugal. Environ Res. 1979 Feb;18(1):152–172. doi: 10.1016/0013-9351(79)90149-x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES